Sigma warns on H1 earnings

Pharmaceuticals group to feel impact of higher cost base on profit.

Sigma Pharmaceuticals Ltd has warned its first-half earnings are likely to come in below the previous corresponding period's as a higher cost base weighs on the group.

In a statement to the Australian Securities Exchange, Sigma flagged a softer result despite trading in the first half being in line with expectations, as well as slightly stronger sales in the same period.

{{content.question}}

SMS Code Sent…

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device


Verify your mobile number to unlock a FREE trial

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa

Related Articles